Latest & greatest articles for children

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on children or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on children and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for children

181. Frenectomy Techniques for Infants with Tongue and Lip Tie: Clinical Effectiveness

Frenectomy Techniques for Infants with Tongue and Lip Tie: Clinical Effectiveness Frenectomy Techniques for Infants with Tongue and Lip Tie: Clinical Effectiveness | CADTH.ca Find the information you need Frenectomy Techniques for Infants with Tongue and Lip Tie: Clinical Effectiveness Frenectomy Techniques for Infants with Tongue and Lip Tie: Clinical Effectiveness Last updated: May 16, 2019 Project Number: RB1340-000 Product Line: Research Type: Devices and Systems Report Type: Summary (...) of Abstracts Result type: Report Question What is the comparative clinical effectiveness between different surgical techniques used to perform frenectomy for infants with tongue and lip tie? Key Message One systematic review was identified regarding frenectomy techniques for infants with tongue and lip tie. Files Rapid Response Summary of Abstracts Published : May 16, 2019 Related Content Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

182. Craniosacral Therapy for Mothers and Infants with Breastfeeding Issues: Clinical Effectiveness

Craniosacral Therapy for Mothers and Infants with Breastfeeding Issues: Clinical Effectiveness Craniosacral Therapy for Mothers and Infants with Breastfeeding Issues: Clinical Effectiveness | CADTH.ca Find the information you need Craniosacral Therapy for Mothers and Infants with Breastfeeding Issues: Clinical Effectiveness Craniosacral Therapy for Mothers and Infants with Breastfeeding Issues: Clinical Effectiveness Last updated: May 23, 2019 Project Number: RB1342-000 Product Line: Research (...) Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of craniosacral therapy for mothers and infants with breastfeeding problems? Key Message One systematic review was identified regarding craniosacral therapy for mothers and infants with breastfeeding issues. Files Rapid Response Summary of Abstracts Published : May 23, 2019 Related Content Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

183. Pediatric Palliative Care Assessment Tools in the Home-Care Setting: Guidelines

Pediatric Palliative Care Assessment Tools in the Home-Care Setting: Guidelines Pediatric Palliative Care Assessment Tools in the Home-Care Setting: Guidelines | CADTH.ca Find the information you need Pediatric Palliative Care Assessment Tools in the Home-Care Setting: Guidelines Pediatric Palliative Care Assessment Tools in the Home-Care Setting: Guidelines Last updated: August 2, 2019 Project Number: RB1372-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts (...) Result type: Report Question What are the evidence-based guidelines regarding home-care assessments for pediatric palliative-care patients? Key Message One evidence-based guideline was identified regarding home-care assessments for pediatric palliative-care patients. Files Rapid Response Summary of Abstracts Published : August 2, 2019 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

184. Care Coordination and Funding of Pediatric Cerebral Palsy in Canada

Care Coordination and Funding of Pediatric Cerebral Palsy in Canada Care Coordination and Funding of Pediatric Cerebral Palsy in Canada | CADTH.ca Find the information you need Care Coordination and Funding of Pediatric Cerebral Palsy in Canada Care Coordination and Funding of Pediatric Cerebral Palsy in Canada Last updated: August 28, 2019 Project Number: ES0340-000 Product Line: Result type: Report Expected Completion Date: March 13, 2020 CADTH is undertaking an Environmental Scan (...) of the models of care coordination and funding that are in place in Canada for children and adolescents living with cerebral palsy (CP). This project is being conducted to help inform decision-making and to support the implementation of best practices to improve the health and well-being of children living with CP. The key objectives of this Environmental Scan are to: determine the current state of care and funding for children and adolescents living with CP in Canada identify and describe the models

2019 Canadian Agency for Drugs and Technologies in Health - Environmental Scanning

185. Blood Culture Frequency in Febrile Pediatric In-patients: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Blood Culture Frequency in Febrile Pediatric In-patients: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Blood Culture Frequency in Febrile Pediatric In-patients: Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Blood Culture Frequency in Febrile Pediatric In-patients: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Blood Culture Frequency in Febrile Pediatric In-patients: Clinical Effectiveness, Cost-Effectiveness (...) , and Guidelines Last updated: June 11, 2019 Project Number: RA1035-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness regarding blood culture examination every 24 hours in febrile pediatric oncology or hematology patients? What is the cost-effectiveness regarding blood culture examination every 24 hours in febrile pediatric oncology or hematology patients? What are the evidence-based guidelines regarding

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

186. Management of Infants at Risk for Group B Streptococcal Disease

Management of Infants at Risk for Group B Streptococcal Disease Management of Infants at Risk for Group B Streptococcal Disease | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact on clinical care. Management (...) information regarding the epidemiology of GBS disease as well current recommendations for the evaluation of newborn infants at risk for GBS disease and for treatment of those with confirmed GBS infection. This clinical report is endorsed by the American College of Obstetricians and Gynecologists (ACOG), July 2019, and should be construed as ACOG clinical guidance. Abbreviations: AAP — American Academy of Pediatrics ABCs — Active Bacterial Core surveillance ACOG — American College of Obstetricians

2019 American Academy of Pediatrics

187. Public health deworming programmes for soil-transmitted helminths in children living in endemic areas Full Text available with Trip Pro

, and addressed comments and criticisms.To summarize the effects of public health programmes to regularly treat all children with deworming drugs on child growth, haemoglobin, cognition, school attendance, school performance, physical fitness, and mortality.We searched the Cochrane Infectious Diseases Group Specialized Register; Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; Embase; LILACS; the metaRegister of Controlled Trials (mRCT); reference lists; and registers of ongoing (...) Public health deworming programmes for soil-transmitted helminths in children living in endemic areas The World Health Organization (WHO) recommends treating all school children at regular intervals with deworming drugs in areas where helminth infection is common. Global advocacy organizations claim routine deworming has substantive health and societal effects beyond the removal of worms. In this update of the 2015 edition we included six new trials, additional data from included trials

2019 EvidenceUpdates

188. The Impact of Severe Maternal Morbidity on Very Preterm Infant Outcomes (Abstract)

The Impact of Severe Maternal Morbidity on Very Preterm Infant Outcomes To estimate the prevalence of severe maternal morbidity among very preterm births and determine its association with very preterm infant mortality and morbidity.This study used New York City Vital Statistics birth and death records linked with maternal and newborn discharge abstract data for live births between 2010 and 2014. We included 6901 infants without congenital anomalies born between 240/7 and 326/7 weeks (...) of gestation. Severe maternal morbidity was identified as life-threatening conditions or life-saving procedures. Outcomes were first-year infant mortality, severe neonatal morbidity (bronchopulmonary dysplasia, severe necrotizing enterocolitis, stage 3-5 retinopathy of prematurity, and intraventricular hemorrhage grades 3-4), and a combined outcome of death or morbidity.Twelve percent of very preterm live-born infants had a mother with severe maternal morbidity. Maternal and pregnancy characteristics

2019 EvidenceUpdates

189. Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis Full Text available with Trip Pro

Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis Topical delgocitinib (JTE-052), a novel Janus kinase inhibitor, had been shown to be clinically effective in adults with atopic dermatitis (AD). However, the efficacy of topical delgocitinib in pediatric patients with AD remained unclear.We sought to evaluate the efficacy and safety of delgocitinib ointment in pediatric patients with AD.In this phase 2 clinical study (JapicCTI-173553) Japanese patients (...) signs and symptoms in pediatric patients with AD and was well tolerated. These study results indicate that delgocitinib ointment can be a promising therapeutic option for pediatric patients with AD.Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

2019 EvidenceUpdates

190. An abnormal cerebroplacental ratio (CPR) is predictive of early childhood delayed neurodevelopment in the setting of fetal growth restriction (Abstract)

An abnormal cerebroplacental ratio (CPR) is predictive of early childhood delayed neurodevelopment in the setting of fetal growth restriction Fetal growth restriction accounts for a significant proportion of perinatal morbidity and death. The cerebroplacental ratio is gaining much interest as a useful tool in differentiating the "at-risk" fetus in both fetal growth restriction and appropriate-for-gestational-age pregnancies. The Prospective Observational Trial to Optimize Pediatric Health (...) in Fetal Growth Restriction group has demonstrated previously that the presence of this "brain-sparing" effect is associated significantly with adverse perinatal outcomes in the fetal growth restriction cohort. However, data about neurodevelopment in children from pregnancies that are complicated by fetal growth restriction are sparse and conflicting.The aim of the Prospective Observational Trial to Optimize Pediatric Health in Fetal Growth Restriction NeuroDevelopmental Assessment Study

2019 EvidenceUpdates

191. Identifying Child Abuse Fatalities During Infancy

childhood deaths from all causes. Many child fatality review teams routinely review sudden unexpected infant deaths. Ideally, a multidisciplinary child death review team should include child welfare or child protective services, law enforcement, public health, the medical examiner or coroner, a pediatrician with expertise in child maltreatment, a forensic pathologist, a representative of the emergency medical services system, a pediatric pathologist, public health and school officials, a local (...) in young children following abuse allegations: evidence from a prospective, population-based study . Christian CW , Block R ; Committee on Child Abuse and Neglect ; American Academy of Pediatrics . Abusive head trauma in infants and children . Choudhary AK , Servaes S , Slovis TL , et al . Consensus statement on abusive head trauma in infants and young children . Chadwick DL , Kirschner RH , Reece RM , et al . Shaken baby syndrome–a forensic pediatric response . Meadow R . Suffocation, recurrent apnea

2019 American Academy of Pediatrics

192. Executive Summary: Criteria for Critical Care of Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance

or injured pediatric patients should be cared for in a child- and family-centered environment by a multidisciplinary pediatric critical care team. Three levels of care are described in these recommendations on the basis of the results of the Delphi survey and expert panel consensus: community-based PICU, tertiary PICU, and quaternary or specialized PICU. Community medical center PICUs play an important role in health care systems that provide care to infants and children. In the previously published (...) Executive Summary: Criteria for Critical Care of Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance Executive Summary: Criteria for Critical Care of Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else

2019 American Academy of Pediatrics

193. Recommendations for Prevention and Control of Influenza in Children, 2019–2020

Recommendations for Prevention and Control of Influenza in Children, 2019–2020 Recommendations for Prevention and Control of Influenza in Children, 2019–2020 | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact (...) on clinical care. Recommendations for Prevention and Control of Influenza in Children, 2019–2020 COMMITTEE ON INFECTIOUS DISEASES Abstract This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019–2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical

2019 American Academy of Pediatrics

194. Tisagenlecleucel (Kymriah) for Pediatric Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma

Tisagenlecleucel (Kymriah) for Pediatric Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma Tisagenlecleucel (Kymriah) for Pediatric Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma | CADTH.ca Find the information you need Tisagenlecleucel (Kymriah) for Pediatric Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma Tisagenlecleucel (Kymriah) for Pediatric Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma Last updated: January 15, 2019 Project (...) Number: OP0538-000 / CT0001 Product Line: Result type: Report Tisagenlecleucel is a chimeric antigen receptor (CAR) T-cell therapy for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma and children and young adults with relapsed or refractory acute lymphoblastic leukemia. CADTH undertook a review of manufacturer-submitted materials and published literature to assess the clinical impact, cost-effectiveness, and implementation considerations, including patient

2019 CADTH - Optimal Use

195. The Australasian Society of Clinical Immunology and Allergy infant feeding for allergy prevention guidelines

access to the MJA is now provided through Wiley Online Library. Preeti A Joshi 1 , 2 Jill Smith 1 Sandra Vale 1 Dianne E Campbell 3 1 Australasian Society of Clinical Immunology and Allergy, Sydney, NSW 2 The Children's Hospital at Westmead, Sydney, NSW 3 University of Sydney, Sydney, NSW Correspondence: Competing interests: Preeti Joshi is currently the chair of the ASCIA paediatric committee and the deputy chair of the National Allergy Strategy allergy prevention project. Sandra Vale is coordinator (...) The Australasian Society of Clinical Immunology and Allergy infant feeding for allergy prevention guidelines The Australasian Society of Clinical Immunology and Allergy infant feeding for allergy prevention guidelines | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect

2019 MJA Clinical Guidelines

196. Vaccine recommendations for children and youth for the 2019/2020 influenza season

Vaccine recommendations for children and youth for the 2019/2020 influenza season The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth 6 months of age and older. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2019/2020 influenza season are not substantially changed from those of last season. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated (...) influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised. However, LAIV will not be available in Canada for the 2019/2020 season. Keywords: Children; Influenza vaccine; Inactivated influenza vaccine; LAIV; NACI

2019 Canadian Paediatric Society

197. Pharmacare in Canada: The Paediatric Perspective

drugs, including child-friendly formulations, improved quality of life for children and families, and cost-savings outside the healthcare system. Regardless of the pharmacare model ultimately implemented, ensuring universal, comprehensive, and portable prescription drug coverage for all children and youth is essential.  To accomplish this, paediatric drug experts should develop a national, evidence-informed formulary of paediatric drugs. Health Canada should also improve processes to make (...) Pharmacare in Canada: The Paediatric Perspective Canada’s drug insurance system is one of the most expensive in the world, yet millions of Canadians still struggle to access necessary medications. As a result, provincial, territorial and federal governments are considering public pharmacare policy proposals to ensure that all Canadians can access the medications they need. Pharmacare policies offer an opportunity to prioritize children and youth, whose unique drug needs have long been

2019 Canadian Paediatric Society

198. Pneumonia in the Immunocompetent Child.

. Hospital-acquired pneumonia developed in non-intensive care units. Respiration 2009;78:416-22. 11. Chang I, Schibler A. Ventilator Associated Pneumonia in Children. Paediatr Respir Rev 2016;20:10-16. 12. Darby JB, Singh A, Quinonez R. Management of Complicated Pneumonia in Childhood: A Review of Recent Literature. Rev Recent Clin Trials 2017;12:253-59. 13. Andronikou S, Goussard P, Sorantin E. Computed tomography in children with community-acquired pneumonia. Pediatr Radiol 2017;47:1431-40. ACR (...) of cavitary necrosis in complicated childhood pneumonia. Eur Radiol 2002;12:391-6. 20. Montella S, Corcione A, Santamaria F. Recurrent Pneumonia in Children: A Reasoned Diagnostic Approach and a Single Centre Experience. Int J Mol Sci 2017;18. 21. Brand PL, Hoving MF, de Groot EP. Evaluating the child with recurrent lower respiratory tract infections. Paediatr Respir Rev 2012;13:135-8. 22. American College of Radiology. ACR–NASCI–SIR–SPR Practice Parameter for the Performance and Interpretation of Body

2019 American College of Radiology

199. Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt (Abstract)

Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt Inflammatory bowel disease (IBD) has been associated with psychiatric morbidity in adults, although previous studies have not accounted for familial confounding. In children, IBD has an even more severe course, but the association between childhood-onset IBD and psychiatric morbidity remains unclear.To examine the risk of psychiatric morbidity in individuals with childhood-onset IBD (...) , controlling for potential confounding shared between siblings.A population-based cohort study was conducted using data from the Swedish national health care and population registers of all children younger than 18 years born from 1973 to 2013. The study included 6464 individuals with a diagnosis of childhood-onset IBD (3228 with ulcerative colitis, 2536 with Crohn disease, and 700 with IBD unclassified) who were compared with 323 200 matched reference individuals from the general population and 6999

2019 EvidenceUpdates

200. Policy on the Use of Dental Bleaching for Child and Adolescent Patients

Policy on the Use of Dental Bleaching for Child and Adolescent Patients OFFICIAL BUT UNFORMATTED Policy on the Use of Dental Bleaching for Child and Adolescent Patients Review Council Council on Clinical Affairs Latest Revision 2019 Purpose The American Academy of Pediatric Dentistry (AAPD) recognizes that the desire for dental whitening in pediatric and adolescent patients has increased. This policy is intended to help professionals and patients make informed decisions about the indications (...) for vital and nonvital teeth. • Patients to consult their dentists to determine appropriate methods for and the timing of dental whitening within the context of an individualized, comprehensive, and sequenced treatment plan. • Dental professionals and consumers to consider side effects when contemplating dental bleaching for child and adolescent patients. • Further research of dental whitening agents in children. The AAPD discourages full-arch cosmetic bleaching for patients in the mixed and primary

2019 American Academy of Pediatric Dentistry